An update on the patent status of Cubicin.
Merck did apply in late March to the US Supreme Court for a review of the patent decision which went against the company. However, it was announced this week that that the request has been declined.
What is still unclear is if Merck will be granted a 6 month paediatric exclusivity patent extension. Certainly a paediatric trial was conducted by Cubicin with this in mind. Without paediatric exclusivity extension, generic entry is possible from later this month. If extension is granted, that date will move back to late December.
http://finance.yahoo.com/news/u-supreme-court-rejects-patent-134059588.html
- Forums
- ASX - By Stock
- That TPM injectable antibiotic...
An update on the patent status of Cubicin. Merck did apply in...
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.2¢ | 0.3¢ | 0.2¢ | $16.54K | 5.758M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 96791453 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 58594028 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 96791453 | 0.002 |
23 | 74000508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 58594028 | 16 |
0.004 | 22905524 | 20 |
0.005 | 20469333 | 10 |
0.006 | 20865067 | 11 |
0.007 | 10865221 | 9 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |